Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Isaac Teitelbaum

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Peritoneal Dialysis
53
2024
84
14.930
 Why?
Kidney Failure, Chronic
40
2023
516
8.090
 Why?
Peritonitis
19
2024
79
3.790
 Why?
Renal Dialysis
18
2022
378
2.730
 Why?
Dialysis Solutions
10
2023
25
1.780
 Why?
Peritoneum
6
2023
36
1.290
 Why?
Kidney
8
2023
1353
1.290
 Why?
Kidney Tubules, Collecting
12
1994
27
0.980
 Why?
Serum Albumin
3
2022
146
0.980
 Why?
Catheters, Indwelling
5
2019
81
0.800
 Why?
Acute Kidney Injury
5
2023
709
0.770
 Why?
Peritoneal Dialysis, Continuous Ambulatory
5
2021
13
0.750
 Why?
Staphylococcus capitis
1
2019
1
0.730
 Why?
Coagulase
1
2019
6
0.730
 Why?
Renal Replacement Therapy
4
2023
70
0.700
 Why?
Renal Insufficiency, Chronic
3
2015
589
0.690
 Why?
Ferric Compounds
2
2022
39
0.680
 Why?
Catheter-Related Infections
1
2019
60
0.680
 Why?
Sucrose
2
2022
104
0.670
 Why?
Quality of Health Care
2
2020
586
0.660
 Why?
Anti-Bacterial Agents
6
2024
1510
0.660
 Why?
Arginine Vasopressin
7
1997
47
0.620
 Why?
Kidney Transplantation
3
2012
585
0.620
 Why?
Hyperphosphatemia
3
2022
14
0.620
 Why?
Staphylococcal Infections
3
2019
346
0.610
 Why?
Peritoneal Fibrosis
1
2017
1
0.600
 Why?
Humans
75
2024
118972
0.590
 Why?
Kidney Function Tests
4
2020
164
0.570
 Why?
Uremia
2
2014
18
0.570
 Why?
Glucans
2
2015
25
0.560
 Why?
Patient-Centered Care
1
2020
497
0.530
 Why?
Therapeutics
1
2015
12
0.520
 Why?
Kidney Medulla
10
1997
32
0.520
 Why?
Body Water
1
2015
28
0.520
 Why?
beta-Cyclodextrins
1
2015
31
0.510
 Why?
Voriconazole
1
2015
24
0.510
 Why?
Phosphates
2
2022
167
0.490
 Why?
Catheterization
3
2016
163
0.490
 Why?
Antifungal Agents
1
2015
134
0.480
 Why?
Chelating Agents
1
2014
74
0.470
 Why?
Blood Pressure
1
2020
1664
0.460
 Why?
GTP-Binding Proteins
6
1995
147
0.440
 Why?
Hemodialysis Solutions
1
2012
4
0.440
 Why?
Type C Phospholipases
6
1992
66
0.430
 Why?
Acidosis
1
2013
86
0.410
 Why?
Hemofiltration
2
2010
31
0.400
 Why?
Kidney Diseases
4
2021
439
0.400
 Why?
Hirudins
1
2010
46
0.380
 Why?
Glucose
2
2015
953
0.380
 Why?
Cyclic AMP
6
1995
242
0.360
 Why?
Urea
4
2021
77
0.360
 Why?
Creatinine
5
2020
491
0.350
 Why?
Heparin
1
2010
230
0.350
 Why?
Kidney Tubules
4
1990
128
0.340
 Why?
Nutritional Status
4
2022
300
0.340
 Why?
Protein Kinase C
5
1995
297
0.340
 Why?
Glomerular Filtration Rate
5
2023
683
0.330
 Why?
Heart Diseases
1
2012
341
0.330
 Why?
Drug Resistance, Bacterial
1
2009
155
0.320
 Why?
Hemodialysis, Home
4
2023
8
0.310
 Why?
Cardiac Surgical Procedures
1
2012
461
0.300
 Why?
Survivors
1
2010
418
0.290
 Why?
Postoperative Complications
3
2012
2235
0.290
 Why?
Peptide Fragments
1
2010
702
0.280
 Why?
Scleroderma, Systemic
1
2007
94
0.280
 Why?
Patient Selection
2
2020
676
0.270
 Why?
Calcium
4
2020
1169
0.270
 Why?
Hernia, Abdominal
1
2005
6
0.270
 Why?
Peritoneal Cavity
1
2005
23
0.270
 Why?
Prospective Studies
11
2023
6471
0.270
 Why?
Patient Participation
2
2020
369
0.260
 Why?
Middle Aged
18
2023
27617
0.260
 Why?
Liver Failure
1
2005
85
0.250
 Why?
Phosphorus
3
2022
84
0.250
 Why?
Time Factors
6
2015
6412
0.250
 Why?
Hemoglobins
2
2020
326
0.250
 Why?
Internationality
3
2020
152
0.250
 Why?
Liver Transplantation
2
2012
847
0.240
 Why?
Quality of Life
5
2020
2366
0.240
 Why?
Teicoplanin
1
2024
17
0.240
 Why?
Blood Chemical Analysis
1
2003
95
0.220
 Why?
Practice Guidelines as Topic
3
2020
1440
0.220
 Why?
Device Removal
2
2019
127
0.220
 Why?
Phosphatidylinositols
3
1991
52
0.210
 Why?
Attitude of Health Personnel
2
2020
992
0.210
 Why?
Rats
13
2014
5392
0.210
 Why?
Contraindications, Procedure
1
2021
9
0.210
 Why?
Goals
2
2020
167
0.210
 Why?
Male
23
2023
57801
0.210
 Why?
Critical Illness
4
2023
662
0.200
 Why?
Nephrologists
1
2021
13
0.200
 Why?
Patient Reported Outcome Measures
2
2020
252
0.200
 Why?
Organism Hydration Status
1
2020
3
0.200
 Why?
Treatment Outcome
9
2020
9342
0.190
 Why?
Liver Cirrhosis
1
2003
245
0.190
 Why?
Superior Vena Cava Syndrome
1
2000
3
0.190
 Why?
Aged
13
2024
19657
0.190
 Why?
Chylous Ascites
1
2000
6
0.190
 Why?
Stress, Psychological
1
2009
972
0.190
 Why?
Female
22
2024
61564
0.190
 Why?
Epidermal Growth Factor
6
1994
173
0.190
 Why?
Acid-Base Equilibrium
1
2020
29
0.190
 Why?
Blood Volume
1
2020
58
0.180
 Why?
Patient Care Planning
1
2020
143
0.180
 Why?
Magnesium
1
2020
150
0.180
 Why?
Potassium
1
2020
132
0.180
 Why?
Risk Factors
6
2023
9000
0.180
 Why?
Physician Executives
1
2019
37
0.170
 Why?
Societies, Medical
2
2020
703
0.160
 Why?
Survival Rate
2
2020
1720
0.160
 Why?
Adult
18
2024
31512
0.160
 Why?
Dogs
2
2023
371
0.160
 Why?
Congresses as Topic
1
2020
204
0.160
 Why?
Drug Combinations
2
2022
291
0.160
 Why?
Kidney Concentrating Ability
1
1997
3
0.160
 Why?
Receptors, Vasopressin
2
1995
25
0.160
 Why?
Renal Insufficiency
1
2020
150
0.160
 Why?
Patient Education as Topic
3
2018
699
0.150
 Why?
Adenylyl Cyclase Inhibitors
2
1994
5
0.150
 Why?
Data Collection
1
2020
658
0.150
 Why?
Adenylyl Cyclases
3
1993
86
0.150
 Why?
Proportional Hazards Models
3
2022
1125
0.140
 Why?
United States
6
2022
12555
0.140
 Why?
Survival Analysis
2
2015
1267
0.140
 Why?
Hormones
2
1994
135
0.130
 Why?
Models, Animal
1
2017
363
0.130
 Why?
Epithelial-Mesenchymal Transition
1
2017
176
0.130
 Why?
Ultrafiltration
1
2015
28
0.130
 Why?
Risk Assessment
3
2016
3057
0.130
 Why?
Curriculum
1
2021
910
0.130
 Why?
Palliative Care
1
2020
629
0.130
 Why?
Sodium
2
2015
200
0.130
 Why?
Lung Injury
1
2017
210
0.120
 Why?
Kaplan-Meier Estimate
2
2015
842
0.120
 Why?
Gastrointestinal Absorption
1
2014
5
0.120
 Why?
Inflammation
3
2017
2566
0.120
 Why?
Diglycerides
2
1993
56
0.120
 Why?
Animals
17
2023
33381
0.120
 Why?
Virulence Factors, Bordetella
2
1991
20
0.120
 Why?
Pertussis Toxin
2
1991
29
0.120
 Why?
Biological Transport
1
2015
382
0.120
 Why?
Treatment Failure
1
2015
341
0.120
 Why?
Didanosine
1
1993
13
0.120
 Why?
Biomedical Research
1
2020
612
0.120
 Why?
Phospholipases A
2
1992
101
0.120
 Why?
Anti-Infective Agents
1
2016
227
0.120
 Why?
Cytosol
1
1994
221
0.120
 Why?
Quality Improvement
1
2020
963
0.110
 Why?
Oleanolic Acid
1
2012
9
0.110
 Why?
HIV Seropositivity
1
1993
111
0.110
 Why?
Methylene Blue
1
2012
24
0.110
 Why?
Tissue Adhesions
1
2012
31
0.110
 Why?
Equipment Design
2
2014
519
0.110
 Why?
Delayed Graft Function
1
2012
26
0.110
 Why?
Hematinics
1
2012
17
0.110
 Why?
Retrospective Studies
6
2023
12978
0.100
 Why?
Vascular Calcification
1
2014
123
0.100
 Why?
Vasoconstrictor Agents
1
2012
122
0.100
 Why?
Receptors, Angiotensin
1
1991
10
0.100
 Why?
Cells, Cultured
9
1994
4077
0.100
 Why?
Nephrectomy
1
2012
162
0.100
 Why?
Atrial Natriuretic Factor
1
1991
59
0.100
 Why?
Bacterial Infections
2
2003
227
0.100
 Why?
Practice Patterns, Physicians'
1
2020
1200
0.100
 Why?
Transplantation, Homologous
1
2012
415
0.100
 Why?
Restless Legs Syndrome
1
2011
19
0.100
 Why?
Hypotension
1
2012
120
0.100
 Why?
Glycerides
1
1990
14
0.100
 Why?
Antithrombins
1
2010
51
0.090
 Why?
Aluminum Compounds
1
1990
7
0.090
 Why?
Phospholipases
1
1990
14
0.090
 Why?
Follow-Up Studies
4
2011
4596
0.090
 Why?
Membranes, Artificial
1
2010
70
0.090
 Why?
Double-Blind Method
2
2012
1687
0.090
 Why?
Virginiamycin
1
2009
3
0.090
 Why?
Linezolid
1
2009
16
0.090
 Why?
Graft Survival
1
2012
504
0.090
 Why?
Daptomycin
1
2009
19
0.090
 Why?
Oxazolidinones
1
2009
14
0.090
 Why?
Models, Biological
1
2017
1715
0.090
 Why?
Acetamides
1
2009
26
0.090
 Why?
Minerals
1
2009
39
0.090
 Why?
Protein Kinases
1
1991
310
0.080
 Why?
Infection Control
1
2010
135
0.080
 Why?
Antibiotic Prophylaxis
2
2022
100
0.080
 Why?
Enzyme Inhibitors
1
2012
827
0.080
 Why?
Hematuria
1
1988
11
0.080
 Why?
Communicable Diseases
1
2010
132
0.080
 Why?
Aged, 80 and over
1
2019
6561
0.080
 Why?
Prognosis
3
2016
3443
0.080
 Why?
Sympathetic Nervous System
1
1989
171
0.080
 Why?
Hepatorenal Syndrome
1
2007
14
0.080
 Why?
Kidney Tubular Necrosis, Acute
1
2007
25
0.080
 Why?
Proteinuria
1
1988
99
0.080
 Why?
RNA, Messenger
1
1995
2657
0.080
 Why?
Enzyme Activation
4
1994
828
0.080
 Why?
Sleep Wake Disorders
1
2011
241
0.080
 Why?
Spondylitis, Ankylosing
1
1988
42
0.080
 Why?
Tetradecanoylphorbol Acetate
3
1993
155
0.080
 Why?
Recombinant Proteins
1
2010
1308
0.070
 Why?
Inositol Phosphates
3
1991
23
0.070
 Why?
ErbB Receptors
1
1990
569
0.070
 Why?
Biopsy, Needle
1
2007
190
0.070
 Why?
Anticoagulants
1
2010
559
0.070
 Why?
Incidence
3
2007
2424
0.070
 Why?
Nephrology
2
2020
50
0.070
 Why?
Hemodialysis Units, Hospital
1
2005
5
0.070
 Why?
Imipenem
1
2005
17
0.070
 Why?
Ethics, Clinical
1
2005
8
0.070
 Why?
Staphylococcus aureus
1
2009
394
0.070
 Why?
Skin Diseases
1
2007
125
0.070
 Why?
Capillaries
1
2005
103
0.070
 Why?
Health Services Accessibility
1
2011
781
0.070
 Why?
Kinetics
3
2017
1624
0.060
 Why?
Vasculitis
1
2005
75
0.060
 Why?
Fibrosis
1
2007
483
0.060
 Why?
Medication Adherence
1
2009
556
0.060
 Why?
Canada
1
2005
340
0.060
 Why?
Gastric Acid
1
2023
15
0.060
 Why?
Disease Models, Animal
1
2014
3730
0.060
 Why?
Bromcresol Green
1
2003
1
0.060
 Why?
Bromcresol Purple
1
2003
1
0.060
 Why?
Nephelometry and Turbidimetry
1
2003
16
0.060
 Why?
Hepcidins
1
2023
24
0.060
 Why?
Combined Modality Therapy
1
2007
1166
0.060
 Why?
Eosinophils
1
2006
282
0.060
 Why?
Indicators and Reagents
1
2003
100
0.060
 Why?
Triglycerides
1
2006
519
0.060
 Why?
Burns
1
2007
247
0.060
 Why?
Permeability
1
2003
156
0.060
 Why?
Drug Resistance
2
2012
167
0.060
 Why?
Equipment Failure
1
2003
114
0.060
 Why?
Lung Transplantation
1
2005
263
0.060
 Why?
Severity of Illness Index
2
2011
2674
0.060
 Why?
Vancomycin
1
2024
79
0.060
 Why?
Inositol 1,4,5-Trisphosphate
2
1994
27
0.060
 Why?
Medicare
2
2022
663
0.060
 Why?
Monocytes
1
2006
513
0.060
 Why?
Cats
1
2023
205
0.050
 Why?
Regression Analysis
1
2005
983
0.050
 Why?
Hypoalbuminemia
1
2022
27
0.050
 Why?
Cohort Studies
4
2020
5116
0.050
 Why?
Ownership
1
2023
79
0.050
 Why?
Patient Compliance
1
2006
537
0.050
 Why?
Phospholipases A2
2
1992
77
0.050
 Why?
Positron-Emission Tomography
1
2023
298
0.050
 Why?
Guanosine 5'-O-(3-Thiotriphosphate)
2
1991
18
0.050
 Why?
Guanosine Diphosphate
2
1991
20
0.050
 Why?
Thionucleotides
2
1991
34
0.050
 Why?
Erythrocytes
1
2006
641
0.050
 Why?
Recurrence
1
2003
975
0.040
 Why?
Dinoprostone
2
1990
193
0.040
 Why?
Child
3
2013
19129
0.040
 Why?
Terminology as Topic
1
2020
211
0.040
 Why?
Chronic Disease
1
2005
1636
0.040
 Why?
Predictive Value of Tests
2
2017
1868
0.040
 Why?
Potassium, Dietary
1
1998
11
0.040
 Why?
Drinking
1
1998
36
0.040
 Why?
Diabetes Mellitus, Type 2
1
2012
2174
0.040
 Why?
Cardiovascular Diseases
1
2010
1798
0.040
 Why?
Sodium, Dietary
1
1998
43
0.040
 Why?
Hyponatremia
1
1998
42
0.040
 Why?
Pilot Projects
1
2022
1419
0.040
 Why?
Diabetic Nephropathies
1
2000
289
0.040
 Why?
Hospitalization
1
2006
1785
0.040
 Why?
Quality Control
1
2017
159
0.040
 Why?
Fluid Therapy
1
2017
130
0.030
 Why?
Dose-Response Relationship, Drug
2
1991
1945
0.030
 Why?
Reproducibility of Results
1
2003
2874
0.030
 Why?
Prostaglandins
1
1995
78
0.030
 Why?
Ionomycin
1
1994
24
0.030
 Why?
Primary Prevention
1
2016
185
0.030
 Why?
Quality Indicators, Health Care
1
2017
295
0.030
 Why?
Calcium-Calmodulin-Dependent Protein Kinases
1
1994
175
0.030
 Why?
Isoproterenol
1
1994
125
0.030
 Why?
Prevalence
2
2011
2326
0.030
 Why?
Colforsin
1
1993
55
0.030
 Why?
Interleukin-6
1
2017
688
0.030
 Why?
Guanylate Cyclase
1
1992
36
0.030
 Why?
Shock, Surgical
1
2012
3
0.030
 Why?
Intraoperative Care
1
2012
39
0.030
 Why?
Catecholamines
1
2012
100
0.030
 Why?
Poisson Distribution
1
2012
68
0.030
 Why?
Sample Size
1
2012
133
0.030
 Why?
Prospective Payment System
1
2011
9
0.030
 Why?
Total Quality Management
1
2011
61
0.030
 Why?
Inositol
1
1991
26
0.030
 Why?
Base Sequence
1
1995
2159
0.020
 Why?
Accreditation
1
2011
87
0.020
 Why?
Receptors, Oxytocin
1
1991
25
0.020
 Why?
Dideoxyadenosine
1
1990
1
0.020
 Why?
Cyclic GMP
1
1991
109
0.020
 Why?
Oxytocin
1
1991
44
0.020
 Why?
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
1
1990
29
0.020
 Why?
Isoquinolines
1
1990
41
0.020
 Why?
Adenosine Diphosphate Ribose
1
1990
8
0.020
 Why?
Molecular Sequence Data
1
1995
2871
0.020
 Why?
Fluorides
1
1990
47
0.020
 Why?
Aluminum
1
1990
34
0.020
 Why?
Guanosine Triphosphate
1
1990
87
0.020
 Why?
Hydrolysis
1
1990
176
0.020
 Why?
Rats, Sprague-Dawley
1
1995
2478
0.020
 Why?
Adrenergic alpha-Agonists
1
1989
31
0.020
 Why?
Adrenergic alpha-Antagonists
1
1989
31
0.020
 Why?
Health Surveys
1
2011
454
0.020
 Why?
Rats, Inbred Strains
1
1989
394
0.020
 Why?
Analysis of Variance
1
2012
1293
0.020
 Why?
In Vitro Techniques
1
1990
1094
0.020
 Why?
Adrenergic beta-Agonists
1
1989
132
0.020
 Why?
Glomerulonephritis, IGA
1
1988
11
0.020
 Why?
Piperazines
1
1990
316
0.020
 Why?
Clinical Trials as Topic
1
2012
969
0.020
 Why?
Cost of Illness
1
2009
258
0.020
 Why?
Adrenergic beta-Antagonists
1
1989
301
0.020
 Why?
Biomarkers
1
2017
3588
0.020
 Why?
Healthcare Disparities
1
2012
496
0.020
 Why?
Morbidity
1
2007
296
0.020
 Why?
Research Design
1
2012
969
0.020
 Why?
Cilastatin
1
2005
3
0.020
 Why?
Hemodiafiltration
1
2005
9
0.020
 Why?
Telemedicine
1
2014
664
0.020
 Why?
Multivariate Analysis
1
2009
1474
0.020
 Why?
Osmolar Concentration
2
1998
185
0.020
 Why?
Protease Inhibitors
1
2005
102
0.020
 Why?
Protein Kinase Inhibitors
1
1990
811
0.020
 Why?
Sensitivity and Specificity
1
2009
1795
0.020
 Why?
Acute Disease
1
2007
940
0.020
 Why?
Comorbidity
1
2009
1527
0.020
 Why?
Biopsy
1
1988
1079
0.020
 Why?
Respiratory Function Tests
1
2005
526
0.010
 Why?
Drug Therapy, Combination
1
2005
965
0.010
 Why?
Graft Rejection
1
2005
555
0.010
 Why?
Immunosuppressive Agents
1
2005
681
0.010
 Why?
Colorado
1
1990
4196
0.010
 Why?
Mice
1
2017
15520
0.010
 Why?
Lung Diseases
1
2005
718
0.010
 Why?
Beer
1
1998
6
0.010
 Why?
Diet, Vegetarian
1
1998
6
0.010
 Why?
Cross-Sectional Studies
1
2009
4552
0.010
 Why?
Urine
1
1998
59
0.010
 Why?
Dietary Proteins
1
1998
130
0.010
 Why?
Signal Transduction
1
1990
4709
0.010
 Why?
Muscarine
1
1994
2
0.010
 Why?
Carbachol
1
1994
20
0.010
 Why?
Vasopressins
1
1994
64
0.010
 Why?
Adolescent
1
2012
18480
0.010
 Why?
Cell Polarity
1
1994
133
0.010
 Why?
Tyrosine
1
1994
233
0.010
 Why?
Purines
1
1994
161
0.010
 Why?
Lung
1
2005
3664
0.010
 Why?
Hypertonic Solutions
1
1991
8
0.010
 Why?
Nocodazole
1
1991
18
0.010
 Why?
Cycloheximide
1
1991
57
0.010
 Why?
Isotonic Solutions
1
1991
43
0.010
 Why?
Culture Media
1
1991
163
0.010
 Why?
Phosphorylation
1
1994
1633
0.010
 Why?
Peptides
1
1994
879
0.010
 Why?
Teitelbaum's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)